{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T07:34:28Z","timestamp":1792481668643,"version":"4.5.0"},"reference-count":211,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Immunity Inflam &amp;amp; Disease"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Today, treating cancer patients with monoclonal antibodies (mAbs), by targeting immune checkpoints, is one of the most outstanding immunotherapeutic methods. Immune checkpoints are special molecules having regulatory role in immune system responses. Once these molecules are presented on cancer cells, these cells will be capable of evading the immune system through their own specific pathways. This Evasion can be prevented by counterbalancing immune system responses with immune checkpoints related antibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aims<\/jats:title><jats:p>The current study aimed to highlight immunotherapy and its methods, describe the immune checkpoints pathways, outline the immune checkpoint inhibitors (ICIs), and recent advances in this field, and sketch an outlook on the best treatment options for the most prevalent cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials &amp; Methods<\/jats:title><jats:p>This research implemented a narrative review method. A comprehensive literature review on the history, molecular and cellular biology, and the clinical aspects of immune checkpoint molecules was performed to illustrate the pathways involved in various cancers. Also, currently\u2010available and future potential immunotherapies targeting these pathways were extracted from the searched studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The immune checkpoint family consists of many molecules, including CTLA\u20104, PD\u20101, PD\u2010L1, LAG\u20103, TIM\u20103, and TIGIT. Attempts to modify these molecules in cancer treatment led to the development of therapeutic monoclonal antibodies. Most of these antibodies have entered clinical studies and some of them have been approved by the Food and Drug Administration (FDA) to be used in cancer patients' treatment plans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>With these novel treatments and the combination therapies they offer, there is also hope for better treatment outcomes for the previously untreatable metastatic cancers. In spite of the beneficial aspects of immune checkpoint therapy, similar to other treatments, they may cause side effects in some patients. Therefore, more studies are needed to reduce the probable side effects and uncover their underlying mechanism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Based on the data shown in this review, there is still a lack of knowledge about the complete properties of ICIs and the possible combination therapies that we may be able to implement to achieve a better treatment response in cancer patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/iid3.70196","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:07:16Z","timestamp":1744895236000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Immune Checkpoint Molecules: A Review on Pathways and Immunotherapy Implications"],"prefix":"10.1002","volume":"13","author":[{"given":"Erfan","family":"Rezazadeh\u2010Gavgani","sequence":"first","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Majidazar","sequence":"additional","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6142-9036","authenticated-orcid":false,"given":"Parisa","family":"Lotfinejad","sequence":"additional","affiliation":[{"name":"Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran"},{"name":"Department of Immunology Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohid","family":"Kazemi","sequence":"additional","affiliation":[{"name":"Immunology Research Center Tabriz University of Medical Sciences Tabriz Iran"},{"name":"Department of Immunology Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-2619","authenticated-orcid":false,"given":"Ali","family":"Shamekh","sequence":"additional","affiliation":[{"name":"Student Research Committee Tabriz University of Medical Sciences Tabriz Iran"},{"name":"Aging Research Institute Tabriz University of Medical Sciences Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.342.6165.1432"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.4161\/2162402X.2014.982382"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dci.2006.06.003"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar4060"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1972"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2003.00009.x"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2007.07.009"},{"key":"e_1_2_13_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270304"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.01.049"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2016.1186827"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1349"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106221"},{"key":"e_1_2_13_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.21.9543-9553.2005"},{"key":"e_1_2_13_15_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.7.1027"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.2.459"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.2000.00121.x"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105282"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2021.1865814"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13407"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001014"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000911"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14030200"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2246-5"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.str.2017.06.011"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05481.x"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(04)00051-2"},{"key":"e_1_2_13_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2016.04.011"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/8.5.773"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.3109\/08916934.2015.1058370"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-019-00456-w"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010038"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.00319-13"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5366.1082"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203818200"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.02.004"},{"issue":"2","key":"e_1_2_13_38_1","first-page":"147","article-title":"Regulation of Ras Signal Transduction During T Cell Development and Activation","volume":"1","author":"Lapinski P. E.","year":"2012","journal-title":"American Journal of Clinical and Experimental Immunology"},{"key":"e_1_2_13_39_1","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2002796"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.147.3.1037"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830181206"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-2980.2010.00462.x"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.7.3489"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2013.05.012"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00259-X"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90071-X"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161206775193046"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00086"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00770.x"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3108"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80480-X"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri1131"},{"key":"e_1_2_13_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80346-5"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.181.1.351"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.24.021605.090535"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5397.2263"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a002279"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-405546-9.00004-2"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00167"},{"key":"e_1_2_13_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80315-5"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208074"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI95837"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.9.4420"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.06.002"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.05.001"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010075"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12070"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12520"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107933"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000957"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.699895"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2018.4661"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83871"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2012.31610"},{"key":"e_1_2_13_75_1","doi-asserted-by":"publisher","DOI":"10.2217\/imt.15.35"},{"issue":"2","key":"e_1_2_13_76_1","first-page":"1","article-title":"Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Markowitz L. E.","year":"2007","journal-title":"MMWR. Recommendations and Reports: Morbidity and mortality Weekly Report"},{"issue":"20","key":"e_1_2_13_77_1","first-page":"630","article-title":"FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance From the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"50","key":"e_1_2_13_78_1","first-page":"1705","article-title":"Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males\u2010\u2010Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)58737-6"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13011"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.239"},{"key":"e_1_2_13_82_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.706186"},{"key":"e_1_2_13_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-014-9542-0"},{"key":"e_1_2_13_84_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33078"},{"key":"e_1_2_13_85_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar6711"},{"key":"e_1_2_13_86_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389201019666180418095526"},{"key":"e_1_2_13_87_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-018-4427-x"},{"key":"e_1_2_13_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2012.08.001"},{"key":"e_1_2_13_89_1","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-018-0191-1"},{"key":"e_1_2_13_90_1","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2020.12070"},{"key":"e_1_2_13_91_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1091-2"},{"key":"e_1_2_13_92_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626616"},{"key":"e_1_2_13_93_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-015-0227-0"},{"key":"e_1_2_13_94_1","doi-asserted-by":"publisher","DOI":"10.2165\/11530960-000000000-00000"},{"key":"e_1_2_13_95_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.1.6.10015"},{"key":"e_1_2_13_96_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-0547"},{"key":"e_1_2_13_97_1","unstructured":"C.Kellner Entwicklung und Charakterisierung bispezifischer Antik\u00f6rper\u2010Derivate zur Immuntherapie CD19\u2010positiver Leuk\u00e4mien und Lymphome Generation and Characterization of Bispecific Antibody\u2010Derivatives for Immunotherapy of CD19\u2010Positive Leukemias and Lymphomas.2008."},{"key":"e_1_2_13_98_1","unstructured":"FDA Approves tebentafusp\u2010tebn for Unresectable or Metastatic Uveal Melanoma. 2022 26\/2\/2022 https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-tebentafusp-tebn-unresectable-or-metastatic-uveal-melanoma."},{"key":"e_1_2_13_99_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1158545"},{"key":"e_1_2_13_100_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.151.5.2877"},{"key":"e_1_2_13_101_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-015-1727-6"},{"key":"e_1_2_13_102_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215570"},{"key":"e_1_2_13_103_1","first-page":"413","article-title":"Radioimmunotherapy of B\u2010Cell Non\u2010Hodgkin's Lymphoma","volume":"3","author":"Cicone F.","year":"2013","journal-title":"Frontiers in Oncology"},{"key":"e_1_2_13_104_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-021-01301-9"},{"key":"e_1_2_13_105_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.6.10.1421"},{"key":"e_1_2_13_106_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600517"},{"key":"e_1_2_13_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2015.05.006"},{"key":"e_1_2_13_108_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2466"},{"key":"e_1_2_13_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4009"},{"key":"e_1_2_13_110_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425247.2018.1517747"},{"key":"e_1_2_13_111_1","doi-asserted-by":"publisher","DOI":"10.3233\/BD-1999-11110"},{"key":"e_1_2_13_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2014.02.002"},{"key":"e_1_2_13_113_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.5625"},{"key":"e_1_2_13_114_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-024-03261-x"},{"key":"e_1_2_13_115_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_2_13_116_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2016-0385"},{"key":"e_1_2_13_117_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.371"},{"key":"e_1_2_13_118_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1302369"},{"key":"e_1_2_13_119_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504030"},{"key":"e_1_2_13_120_1","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820967454"},{"key":"e_1_2_13_121_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2016.1211936"},{"key":"e_1_2_13_122_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12180"},{"key":"e_1_2_13_123_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-7-873"},{"key":"e_1_2_13_124_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-018-0718-6"},{"key":"e_1_2_13_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.07.045"},{"key":"e_1_2_13_126_1","doi-asserted-by":"publisher","DOI":"10.1177\/1758834014567470"},{"key":"e_1_2_13_127_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-3452"},{"key":"e_1_2_13_128_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.107796"},{"key":"e_1_2_13_129_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2015.991819"},{"key":"e_1_2_13_130_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2018.1535315"},{"key":"e_1_2_13_131_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0339-5"},{"key":"e_1_2_13_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30738"},{"key":"e_1_2_13_133_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-1417"},{"key":"e_1_2_13_134_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.74.9846"},{"key":"e_1_2_13_135_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0749-6"},{"key":"e_1_2_13_136_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021273"},{"key":"e_1_2_13_137_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.02105"},{"key":"e_1_2_13_138_1","doi-asserted-by":"publisher","DOI":"10.1186\/2051-1426-3-S2-O7"},{"key":"e_1_2_13_139_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0782-5"},{"key":"e_1_2_13_140_1","unstructured":"clinicaltrials.gov search results Dostarlimab."},{"key":"e_1_2_13_141_1","unstructured":"FDA JEMPERLI (dostarlimab\u2010gxly) Injection for Intravenous use Initial U.S. Approval: 20212021."},{"key":"e_1_2_13_142_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0011-0"},{"key":"e_1_2_13_143_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1617941114"},{"key":"e_1_2_13_144_1","unstructured":"Clinical Trials Around the World for Ipilimumab. 24\/4\/2022] https:\/\/www.clinicaltrials.gov\/ct2\/results?cond=&term=ipilimumab&cntry=&state=&city=&dist=."},{"key":"e_1_2_13_145_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-020-00946-3"},{"key":"e_1_2_13_146_1","unstructured":"FDA FDA Grants Accelerated Approval to Dostarlimab\u2010Gxly for dMMR Advanced Solid Tumors.2021."},{"key":"e_1_2_13_147_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1716948"},{"key":"e_1_2_13_148_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12624"},{"key":"e_1_2_13_149_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2020.1732211"},{"key":"e_1_2_13_150_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002788"},{"key":"e_1_2_13_151_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1551671"},{"key":"e_1_2_13_152_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.10.002"},{"key":"e_1_2_13_153_1","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2019.1635115"},{"key":"e_1_2_13_154_1","doi-asserted-by":"publisher","DOI":"10.3945\/an.116.012211"},{"key":"e_1_2_13_155_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_13_156_1","doi-asserted-by":"publisher","DOI":"10.12968\/hmed.2019.80.12.720"},{"key":"e_1_2_13_157_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-56673-3"},{"key":"e_1_2_13_158_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2019.10.013"},{"key":"e_1_2_13_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103197"},{"key":"e_1_2_13_160_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103223"},{"key":"e_1_2_13_161_1","doi-asserted-by":"publisher","DOI":"10.4081\/oncol.2021.497"},{"key":"e_1_2_13_162_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.24.18_suppl.7082"},{"key":"e_1_2_13_163_1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12916"},{"key":"e_1_2_13_164_1","unstructured":"Lung Cancer Survival Rates. 1\/5\/2022 https:\/\/www.cancer.org\/cancer\/lung-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"key":"e_1_2_13_165_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-019-03070-3"},{"key":"e_1_2_13_166_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.03.016"},{"key":"e_1_2_13_167_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0248"},{"key":"e_1_2_13_168_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106452"},{"key":"e_1_2_13_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.05.029"},{"key":"e_1_2_13_170_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238536"},{"issue":"4","key":"e_1_2_13_171_1","article-title":"Single or Combined Immune Checkpoint Inhibitors Compared to First\u2010Line Platinum\u2010Based Chemotherapy With or Without Bevacizumab for People With Advanced Non\u2010Small Cell Lung Cancer","volume":"12","author":"Ferrara R.","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_13_172_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1774314"},{"key":"e_1_2_13_173_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102893"},{"key":"e_1_2_13_174_1","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-6191"},{"key":"e_1_2_13_175_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00442-8"},{"key":"e_1_2_13_176_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.02.018"},{"key":"e_1_2_13_177_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00339-4"},{"key":"e_1_2_13_178_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy145"},{"key":"e_1_2_13_179_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25564"},{"key":"e_1_2_13_180_1","unstructured":"Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies. 27\/4\/2022 https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03367819."},{"key":"e_1_2_13_181_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020334"},{"key":"e_1_2_13_182_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.647110"},{"key":"e_1_2_13_183_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0189-8"},{"issue":"5","key":"e_1_2_13_184_1","first-page":"331","article-title":"Care of the Colorectal Cancer Survivor","volume":"97","author":"Burgers K.","year":"2018","journal-title":"American Family Physician"},{"key":"e_1_2_13_185_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2020-0040"},{"key":"e_1_2_13_186_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-021-04028-z"},{"key":"e_1_2_13_187_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-64830-5_5"},{"key":"e_1_2_13_188_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000002108"},{"key":"e_1_2_13_189_1","unstructured":"National Cancer Institute SEER Program. Cancer stat facts: melanoma of the skin. 2011\u20132017 26\/2\/2022 https:\/\/seer.cancer.gov\/statfacts\/html\/melan.html."},{"key":"e_1_2_13_190_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1104621"},{"key":"e_1_2_13_191_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61397-0"},{"key":"e_1_2_13_192_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01206-X"},{"key":"e_1_2_13_193_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.1611"},{"key":"e_1_2_13_194_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.781162"},{"key":"e_1_2_13_195_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103304"},{"key":"e_1_2_13_196_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vhri.2021.04.007"},{"key":"e_1_2_13_197_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.953884"},{"key":"e_1_2_13_198_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706"},{"key":"e_1_2_13_199_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4236"},{"key":"e_1_2_13_200_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-327209"},{"key":"e_1_2_13_201_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072217"},{"key":"e_1_2_13_202_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-024-01622-6"},{"key":"e_1_2_13_203_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012818"},{"key":"e_1_2_13_204_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2021.1952073"},{"key":"e_1_2_13_205_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02801-2"},{"key":"e_1_2_13_206_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315537"},{"key":"e_1_2_13_207_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.6378"},{"issue":"2","key":"e_1_2_13_208_1","doi-asserted-by":"crossref","DOI":"10.1158\/2326-6074.IO2025-A099","article-title":"Abstract A099: The IO\u2010Atlas Project: A Cross\u2010Cohort Tumor Immunophenotyping Platform Enhancing Precision Immuno\u2010Oncology","volume":"13","author":"Ma L.","year":"2025","journal-title":"Cancer Immunology Research"},{"key":"e_1_2_13_209_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1388156"},{"key":"e_1_2_13_210_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1446522"},{"key":"e_1_2_13_211_1","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13876"},{"key":"e_1_2_13_212_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S268032"}],"container-title":["Immunity, Inflammation and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/iid3.70196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T10:56:01Z","timestamp":1745837761000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/iid3.70196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":211,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1002\/iid3.70196"],"URL":"https:\/\/doi.org\/10.1002\/iid3.70196","archive":["Portico"],"relation":{},"ISSN":["2050-4527","2050-4527"],"issn-type":[{"value":"2050-4527","type":"print"},{"value":"2050-4527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2024-05-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70196"}}